Evidence map›Paper›PMID 33402508›Full record

ArticleIn vivo (Athens, Greece)

Preoperative Octenidine Application in Breast Reconstruction Surgery.

Jens Hachenberg, Ellen Acis, Maximilian Mattes Auer-Schmidt, Mathias Warm, Wolfram Malter, Fabinshy Thangarajah, Christian Eichler

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jens Hachenberg *Department of Gynecology and Obstetrics, Hannover Medical School, Hannover, Germany; Hachenberg.Jens@mh-hannover.de.
Ellen AcisDepartment of Gynecology and Obstetrics, University of Cologne, Cologne, Germany.
Maximilian Mattes Auer-SchmidtFaculty of Medicine and University Hospital Cologne, The University of Cologne, Cologne, Germany.
Mathias WarmDepartment of Gynecology and Obstetrics, University of Cologne, Cologne, Germany.
Wolfram MalterDepartment of Gynecology and Obstetrics, University of Cologne, Cologne, Germany.
Fabinshy ThangarajahDepartment of Gynecology and Obstetrics, University of Cologne, Cologne, Germany.
Christian Eichler *Department of Gynecology and Obstetrics, University of Cologne, Cologne, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimPostoperative infection in implant-based reconstructive breast surgery is a common problem. The preoperative application of a disinfecting washing agent may reduce postoperative infection rates. This retrospective analysis aimed to evaluate whether preoperative Octenisan PATIENTS AND

methodsBetween 2016 and 2019, 127 women received implant-based breast reconstruction at the municipal hospital of Cologne, Holweide, Germany. A total of 197 treatments were performed. After giving consent, patients were asked to use Octenisan

resultsPatient adherence to the application regimen was 48.7%. Overall minor complications occurred in 34.4% with preoperative Octenidine usage and 36.6% without preoperative Octenidine usage. Major complications happened in 7% with preoperative Octenidine and 5% without Octenidine. Overall, there was no significant difference concerning minor or major complication rates.

conclusionPreoperative washing protocols involving the Octenisan

Indexed as

Breast ImplantationBreast ImplantsBreast NeoplasmsMammaplastyFemaleGermanyHumansIminesPostoperative ComplicationsPyridinesRetrospective StudiesStaphylococcus aureusIminesoctenidinePyridinesbreast reconstruction surgeryOctinidinePreoperative body washingtopical antiseptics

Identifiers

PMID33402508
PMCPMC7880775

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.